|
LTV1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.937000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.982000E-01 |
| Normal-vs-Stage2 |
3.328400E-01 |
| Normal-vs-Stage3 |
4.097000E-01 |
| Normal-vs-Stage4 |
6.423400E-01 |
| Stage1-vs-Stage2 |
4.404600E-01 |
| Stage1-vs-Stage3 |
6.671600E-01 |
| Stage1-vs-Stage4 |
2.641600E-01 |
| Stage2-vs-Stage3 |
6.977200E-01 |
| Stage2-vs-Stage4 |
1.949990E-01 |
| Stage3-vs-Stage4 |
1.959820E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.413800E-01 |
| Normal-vs-AfricanAmerican |
6.787200E-01 |
| Normal-vs-Asian |
2.828400E-01 |
| Caucasian-vs-AfricanAmerican |
2.414400E-01 |
| Caucasian-vs-Asian |
1.998810E-01 |
| AfricanAmerican-vs-Asian |
4.707400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.511820E-01 |
| Normal-vs-Female |
2.872400E-01 |
| Male-vs-Female |
3.391500E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.364600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.024400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.634800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.677640E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.787600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.885800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.464400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.706600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.238200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.987180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.293000E-01 |
| Normal-vs-Grade 2 |
7.089800E-01 |
| Normal-vs-Grade 3 |
4.010200E-02 |
| Normal-vs-Grade 4 |
8.272000E-01 |
| Grade 1-vs-Grade 2 |
4.011400E-01 |
| Grade 1-vs-Grade 3 |
1.427550E-01 |
| Grade 1-vs-Grade 4 |
4.812800E-01 |
| Grade 2-vs-Grade 3 |
1.064470E-03 |
| Grade 2-vs-Grade 4 |
9.320400E-01 |
| Grade 3-vs-Grade 4 |
6.048500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.378200E-01 |
| Normal-vs-ccB subtype |
8.420400E-02 |
| ccA subtype-vs-ccB subtype |
2.396200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.055000E-01 |
| Normal-vs-N1 |
9.582600E-01 |
| N0-vs-N1 |
9.814800E-01 |
|
|
